Immunotherapy - Tumors
The mainstay of cancer treatment has historically involved therapies, such as surgery, chemotherapy or radiation that were developed without regard for the patient's immune system. These therapies include nonspecific activation of the immune system using tollâ€like receptor ligands, cytokines or immune checkpoint inhibitors, or specific treatments, like monoclonal antibody administration or vaccination, that directly target cancer cells. Perhaps, the most promising specific therapy is the adoptive transfer of genetically engineered tumourâ€reactive T cells, an approach that has already proven curative in some patients with metastatic disease. Cumulatively, these new immuneâ€based approaches have great promise to revolutionise cancer therapy.
- Immune system stimulants
- Tumor antigens
- Anti tumor response
- Out comes
Related Conference of Immunotherapy - Tumors
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
Immunotherapy - Tumors Conference Speakers
Recommended Sessions
- Antibody Therapy of Cancer
- Brain Tumors
- Cancer biomarkers
- Cancer clinical trials
- Cancer Immunology & Immunotherapy
- Cancer micro and immuno environment
- Cancer Research
- Cancer vaccines
- Combining Cancer Immunotherapies
- Engineered T-Cell Therapy
- Immune checkpoint inhibitors
- Immuno-Oncology studies
- Immunotherapy - Tumors
- Immunotherapy Monitoring
- Novel Approaches in Cancer & Tumor
- Tumor biology
- Tumor Immunogenicity
- Tumor Immunology
- Tumor immunotherapy research
- Tumor markers and drug targeting
- Tumorigenesis
- Tumors
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)